Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension

NCT01915940 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Bimatoprost
DRUG: Timolol 0.5%
DRUG: Placebo Eye Drops
DEVICE: Placebo Ocular Insert

Sponsor

ForSight Vision5, Inc.